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Abstract: Characteristics of each asthma type classified by clinical symptoms and
findings were studied in 72 patients with bronchial asthma. 1. Ventilatory function
tests showed that the values of %MMF, %V50 and %V25 were significantly lower in
patients with bronchiolar obstruction (type II) compared to the values of those with
simple bronchoconstriction type (type la) and those with bronchoconstriction +
hypersecretion (type Ib). 2. The proportion of neutrophils in bronchoalveolar lavage
(BAL) fluid was significantly higher in type II than in type la and type lb. Several
patients with type Ib showed higher proportion of BAL eosinophils. 3. The release of
LTC. from leucocytes was significantly lower in type II compared with type la and type
lb. There was no significant difference in the release of histamine and LTB. among the
three asthma types.
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Introduction
Bronchial asthma is characterized by tran-
sient bronchoconstriction, accompanied with
edema of mucous membrane and hypersecret-
ion. The pathophysiological changes in bron-
chial asthma can be observed by clinical
symptoms during asthma attacks. In adult
asthma cases, the attacks tend to be chronic
and severe. Therefore, it is often difficult for
physicians to control their attacks with usual
medication except corticosteroid hormone.
Our previous studies have shown that
bronchial asthma can divided into three
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clinical types according to the symptoms and
findings (1-3). In the present studies, charac-
teristics of each asthma type were examined
by analyzing cellular composition of broncho-
alveolar lavage (BAL) fluid and release of
chemical mediators from leucocytes.
Subjects and Methods
The subjects were 72 patients with bron-
chial asthma (45 females and 27 males). The
mean age of the subjects was 55.5 years
(range; 26-76 years). The mean conccentra-
tion of total IgE was 372 IU/mP (range; 48-
3200 IU/mi). Of 72 subjects, 26 (36.1%)
had been on corticosteroid therapy for longer
than two years, and 19 (26.4%) were sensi-
tive to house dust mite. They were all non-
smokers, because smokers were excluded
before analysis of data in this study.
Bronchoalveolar lavage (BAL) was per-
formed according to the method previously
described (4,5) during attack-free stages.
Informed consent for the BAL examination
was accepted by subjects. After the aspirates
were centrifuged at 1200 rpm for 10 min at
4°C, the cell pellet was resuspended in Tris
ACM. Smear preparations were made using
the cell suspension. The slides were air-dried
and stained with May-Giemsa. A differential
cell count was carried out on 500 cells exclud-
ing epithelial cells. In this study, the mean
recovery rate at BAL was 26.8 ± 9.9% (mean
±SD).
The subjects were classified into three types
of asthma according to their clinical symp-
toms and findings (1-- 3). The cases, whose
symptoms, wheezing and dyspnea, were assess-
ed to be elicited mainly by bronchoconstriction,
were evaluated as Ia. simple bronchocon-
striction type. The cases, whose symptoms
were due to hypersecretion (more than 100mP
/ day of expectoration), III addition to
bronchoconstriction, were evaluated as lb.
bronchocon-striction + hyperssecretion type.
The subjects, whose symptoms were assessed
to be caused by bronchiolar obstruction, in
addition to bronchoconstriction or hyper-
secretion, were estimated as II. bronchiolar
obstruction type.
The release of chemical mediators, hista-
mine, leukotriene B, (LTB,) and leukotriene
C, (LTC,), from peripheral leukocytes was
examined by stimulation with Ca ionophore
A 23187 (1.0 f..lg/mP). Cells were separated by
counterflow centrifugation elutriation using a
JE-6B rotor (Beckman) (6,7). Venous blood
(17.5mP) was drawn into a test tube contain-
ing 2.5mP of 0.1 M EDTA. After centrifuga-
tion for 8 min at 500 rpm, the supernatant
was removed, and the precipitate was trans-
ferred into the rotor with the buffer (pH 7.2,
osmotic pressure 325 mOsm/kgH20) contain-
ing 1/10 M phosphate buffer, 0.14 M NaCl
and 2% (w/v) bovine serum albumin (6).
The sample flowing out of the rotor for 8
min at a flow rate of 4.5mP/min was col-
lected into a test tube. After the rotor was
washed out with the buffer for 10 min, the
procedure for cell separation was started at a
flow rate of 6mP/min. The flow rate was
increased by 1mP per 4 min, followed by the
collection of cells into a test tube. The final
flow rate was 15mP / min. The experiments
were performed under 4°C at 2000 rpm (8).
The cells separated at flow rate of 4.5 to 10
mP/min were applied for the experiment of
histamine release and cells at flow rate 11 to
15mP/min for the experiments of leukotrienes
release. The histamine content of the cells
and the supernatant fluid was analyzed by
perchloric acid precipitation and assayed by
an automated spectrofluorometric histamine
analysis system (Technicon) (9 - 11). The
results were expressed as a percent release of
38 Humoral and cellualr factors III asthma
Age, years Serum IqE
Clinical type Mean Range No (IU/ml)
Ia 53.8 26-74 35 429 ± 543*
Ib 56.7 28-70 25 384 ± 511
II 58.2 37-76 12 180 ± 89
*Mean ± sd
3. Cellular composition in SAL fluid of each
asthma type
The proportion of macrophages in BAL
fluid was significantly higher in type Ia
(78.6±14.9%) than in type II (61.5±22.0%)
(p<O.01). The proportion of BAL lympho-
cytes was similar from 14.1% to 15.9% in
three asthma types, and no significant differ-
ence was found among them. Marked increase
in the proportion of BAL neutrophils was
observed in type II cases, whose ventilatory
. .
parameters such as %MMF, %V50 , and %V,.;
representing small airway dysfunction was
very low. The proportion of BAL neutrophils
(20.5 ± 25.1%) in type II cases was signifi-
cantly higher compared with that in type Ia
(2.1±2.6%) (p<O.OO1) and type Ib (4.8±7.1
%) (p<O.01). The proportion of BAL
neutrophils in type Ib was greater than the
proportion in type la, although no significant
difference was found between them. Relating
to eosinophils, the proportion in type Ib was
highest(l8.1±11.3%)among the three asthma
types. Several cases with high proportion of
eosinophils, who were cases with so-called
intrinsic asthma accompanied with eOSlll-
ophilia and hypersecretion in the airways,
were included in type lb. No significant
the total histamine content. The release of
leucotrienes was evaluated by measuring the
content of leukotrienes in the supernatant by
a HPLC and the results were expressed as
ng/10 G cells.
The level of total IgE in sera was measured
by radioimmunosorbent test (RIST).
Results
1. Ventilatory function in each clinical
asthma type
To demonstrate the characteristics of aIr-
way disorder III each asthma type,
ventilatory function test was carried out in
all subjects during attack-free stages.
Table 1 presents the results of ventilatory
function in each asthma type. The value of
each ventilatory prameter was generally low
in type II and marked difference was found in
%MMF, %V50 and %V'5 between type la or Ib
and type II (Table 1).
Table 1. Ventilatory function in patients
with bronchial asthma III relation
to clinical type
Clinica 1 type %FVC FEV 1 • 0 % %PEFR %MMF %V SO %V 25
Ia 93.4 69. ,a 80.7 49.6b 41.2d 30.7£
t'19.2 ±13.0 t26.2 .t24.0 ±20.2 ±17.6
rb 104.1 68.6 81.6 43.6e 36.7e 26. sq
±20.8 .9.9 t20.0 t21 .7 ±19.2 t14.7
II 81. J GO.Sa 64.2 17.3b ,c 12_0d ,e 9.3£ ,g
:t26.4 .t12.1 ±22.7 , B.l , 7.0 .6. S
Ia :simple hronchoconstriction type, Ib :bronchoconstriction +
hypersecretion type. II :bronchiolar obstruction type.
a : p< 0.05, b,c,d,f,9 : p <0.001. e : p (0.01.
2. Characteristics of the subjects studied
The subjects were classified into three
clinical asthma types. No significant differ-
ence was present in the mean age among
three asthma types. Serum concentration of
total IgE was lowest in type II asthma,
although any significant difference was not
present among them (Table 2).
Table 2. Characteristics of
bronchial asthma
clinical symptoms
patients with
classified by
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difference was, however, present in the pro-
portion of BAL eosinophils among them (Fig.
O.
difference was foud in the release of LTB.
among the three asthma types (Fig. 2).
Clinical asthma type
Cellular composition in BALF of
patients with bronchial asthma in
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4. Release of chemical mediators from
leucocytes
Histamine release from leucocytes induced
by Ca ionophore A23187 was the highest in
type la (17.0±14.8%) and the lowest in type
II (12.0±9.2%), although there was no sig-
nificant difference between them. The release
of LTC. from leucocytes by Ca ionophore
A23187 was significantly higher in type la
(11.5±1O.7ng/lO'cells) than in type II (4.1
±4.1ng/l0'cells) (p<0.05). The value of LT
C. induced by Ca ionophore A23187 was 8.7
± 6.9ng/l0' cells in type lb. The release
of LTB. from leucocytes was 39.5 ± 20.9ng/
10 6 cells in type la, 37.1 ±21.3ng/l0'cells in
type lb and 39.1 ±21.2ng/l0 6 cells in type II.
The values were similar and no significant
Recently, the role of inflammatory re-
sponse including inflammatory mediators and
cells has be noticed in the pathogenesis of
bronchial asthma. Inflammatory mediators
have been demonstrated to increase in BAL
fluid during the time of the immediate asth-
matic response (IAR), and that of the late
asthmatic response (LAR) (12, 13), which is
associated with inflammatory cells. It has
been reported that an increased number of
lymphocytes (14-16) and eosinophils (17, 18)
in BAL fluid was observed in asthma pa-
tients. While there are only a few reports on
the changes in number of neutrophils in BAL
fluid of asthmatics (19). Boichot et al (20)
have observed bronchopulmonary response to
acetylcholine and 5-hydroxytryptamine IS
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enhanced 3-4 hr and 18-24 hr after antigen
exposure of sensitized animals. At the same
time, they showed a significant increase in
the number of neutrophils in BAL fluid 3 - 4
hr after the exposure of sensitized animals to
antigen, which was associated with a signifi-
cant eosinophilia at 18-24 hr. Thus, inflam-
matory mediators and cells participate in the
pathogenesis of human asthma.
Asthma symptoms are variegated. Some
patients show strong wheezing with dyspnea
during their asthma attacks. Other patients
show no or a little wheezing inspite of
dyspnea, and several patients have a lot of
expectoration. Our previous studies have
demonstrated that bronchial asthma can be
classified into three clinical types according
to their symptoms and findings (1-3). In this
study, to analyze the characteristcs of each
asthma type, cellular composition in BAL
fluid and the release of chemical mediators
from leucocytes of each clinical asthma type
were compared among the three clinical
asthma types. Ventilatory function test
demonstrated that the values of %MMF, %
V50 and %V25, which are estimated to repre-
sent the dysfunction of the small airways,
were markedly decreased in type II cases.
There was no significant difference in venti-
latory function beween type Ia and type Ib,
although the subjects in both types showed
an obstructive ventilatory pattern with a
decrease in FEV 1.0.
The data from the present study reveal
that the proportion of neutrophils in BAL
fluid was significantly higher in type II
(bronchiolar obstruction type) compared with
types la and lb, demonstrating the participa-
tion of neutrophils in bronchiolar obstrution.
The proportion of eosinophils was increased
in some cases of type lb, which included
several so-called intrinsic asthma accom-
panied with eosinophilia and hypersecretion in
the airways. Relating to release of chemical
mediators, the release of LTC. was signifi-
cantly lower in type II than in type la, sug-
gesting that type II cases are characteristic
of higher proportion of neutrophils in BAL
fluid and less release of LTC •. The release of
histamine and LTB. from leucocytes showed
no significant difference among the three
asthma types.
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気管支唱息の臨床分類とその細胞性および液性因
子の特徴
谷崎勝朗,貴谷 光,御船尚志,光延文裕,梶本
和宏,杉本啓介,横田 聡,平松順一,瓦臣正志,
中桐善康 1),多田慎也2),木村郁郎2)
岡山大学医学部附属病院三朝分院内科, 1)産婦人
料, 2)医学部第2内科
気管支鴨息72例を対象に,その臨床病態の特徴
を,気道炎症性の細胞および化学伝達物質の観察
により検討した｡
1.気道反応の特徴を換気機能の面から検討する
と,II細気管支閉塞型において,MMF,寸 50
や0 25などの小ないし細気管支領域の換気障害
を示すパラメーターの値は,Ia型,Ib型に比べ
有意の低下を示した｡
2.気道細胞反応では,Ⅰ型において,他の臨床
病型に比べ,BAL液中好中球の出現頻度の有
意の増加が観察された (Ia,p<0.001;Ib,
p<0.01)｡好酸球の出現頻度は,Ib過分泌型
において著しい増加傾向を示す症例が見られた
が,その平均出現頻度には3病型間に有意の差
は見られなかった｡
3.好中球からのメジェ一夕-遊離では,ヒスタ
ミン遊離は,Ia単純性気管支撃縮型において最
も高い値が示されたが,推計学的には3病型間
に有意の差は見られなかった｡ロイコトリエン
C4では,Ia型においてⅠ型に比べ有意に高い遊
離が観察された (p<0.05)｡ロイコトリエン
B4遊離には,3病型間に差は見られなかった｡
